Encouraging results from Phase 1/2 study of mirdametinib in pediatric patients with low-grade glioma also to be presented in oral session at SNO – STAMFORD, Conn., (GLOBE NEWSWIRE) -- SpringWorks ...
Introduction This is the wrap-up column treating with a retrospective and prospective reflection and review of the ruling Stabroek PSA and its Model PSA ...
Sign up for The Daily Alert - Stay on top of our latest content with links to all the digital articles, videos, and podcasts published in the past 24 hours.